PMBCX Performance — MidCap Fund, Class C
Data updated: 2026-09-25
PMBCX returned −5.03% year to date and −10.04% over one year to Jul 2026. Annualised returns are +6.78% over 3 years and +2.59% over 5 years. The fund trailed its US Mid-Cap Blend category average: $100 invested three years ago grew to $122, against $144 for the category, and to $90 over one year, against $119. Volatility over the past three years was 15.16% a year. In the 12 months to Jul 2026 the fund lost a net $4.7B, and assets reached $23.10B.
PMBCX Growth of $100
What $100 invested in MidCap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Blend category average over the same months.
| Period | PMBCX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $90 | $119 |
| 3 years (Aug 2023 – Jul 2026) | $122 | $144 |
| 5 years (Aug 2021 – Jul 2026) | $114 | $145 |
| Since data start (Aug 2019 – Jul 2026) | $167 | $204 |
PMBCX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −5.03% |
| 1 year | −10.04% |
| 3 years (annualised) | +6.78% |
| 5 years (annualised) | +2.59% |
PMBCX Annual Returns
Calendar-year total returns of MidCap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −5.03% |
| 2025 | +0.50% |
| 2024 | +18.74% |
| 2023 | +24.50% |
| 2022 | −23.99% |
| 2021 | +24.10% |
| 2020 | +17.09% |
| 2019 (Aug–Dec) | +7.23% |
PMBCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.7% | −3.2% | −7.7% | +3.5% | +0.7% | +1.9% | +0.8% | — | — | — | — | — |
| 2025 | +5.2% | −1.3% | −4.3% | −0.6% | +3.8% | +2.7% | +0.8% | +0.6% | −1.5% | −4.3% | +1.1% | −1.2% |
| 2024 | +1.0% | +5.6% | +3.7% | −6.4% | +3.3% | +0.4% | +6.2% | +1.8% | +2.3% | −0.9% | +8.9% | −7.4% |
| 2023 | +8.4% | −3.1% | +0.3% | +2.0% | −0.8% | +8.1% | +0.7% | −1.0% | −5.2% | −3.4% | +12.4% | +5.4% |
| 2022 | −10.7% | −3.8% | +2.6% | −8.8% | −0.7% | −8.5% | +11.0% | −4.0% | −9.4% | +7.0% | +7.4% | −6.3% |
| 2021 | −4.5% | +5.8% | +2.2% | +6.4% | +0.3% | +2.2% | +4.0% | +0.3% | −3.7% | +7.5% | −3.2% | +5.5% |
| 2020 | +3.2% | −7.0% | −20.8% | +13.2% | +8.9% | +1.1% | +6.0% | +4.2% | −2.4% | −2.3% | +12.8% | +4.2% |
| 2019 | — | — | — | — | — | — | — | +0.5% | +0.7% | +1.5% | +3.0% | +1.3% |
PMBCX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 15.16%
- 3-year Sharpe ratio: 0.15 (vs 4.5% risk-free rate)
- Best month: +12.44% (Nov 2023)
- Worst month: −7.68% (Mar 2026)
PMBCX Fund Flows
Monthly money in and out of MidCap Fund, from SEC Form N-PORT.
- 12-month net flow: −$4.7B
- 12-month gross sales (incl. reinvestments): $8.0B
- Sales ÷ redemptions: 0.63×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $246.2M | $1.2B | −$989.6M |
| Jun 2026 | $267.5M | $1.4B | −$1.1B |
| May 2026 | $626.4M | $1.4B | −$808.6M |
| Apr 2026 | $398.0M | $1.4B | −$1.0B |
| Mar 2026 | $450.0M | $1.9B | −$1.4B |
| Feb 2026 | $540.4M | $990.8M | −$450.4M |
| Jan 2026 | $664.8M | $841.3M | −$176.5M |
| Dec 2025 | $2.1B | $1.1B | $927.6M |
| Nov 2025 | $495.6M | $697.7M | −$202.1M |
| Oct 2025 | $623.8M | $831.2M | −$207.4M |
| Sep 2025 | $922.7M | $371.0M | $551.8M |
| Aug 2025 | $669.0M | $403.0M | $266.0M |
PMBCX Assets Under Management
Net assets of MidCap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $23.10B |
| 2026-04-30 | $25.19B |
| 2026-01-31 | $30.25B |
| 2025-10-31 | $31.58B |
| 2025-07-31 | $32.61B |
| 2025-04-30 | $29.49B |
| 2025-01-31 | $30.41B |
| 2024-10-31 | $28.09B |
| 2024-07-31 | $26.19B |
| 2024-04-30 | $23.04B |
| 2024-01-31 | $21.98B |
| 2023-10-31 | $18.22B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.